Registro:

Referencias:

• Williams, S.E., Brown, T.I., Roghanian, A., Sallenave, J.M., SLPI and elafin: one glove, many fingers (2006) Clin Sci (Lond), 110, pp. 21-35
• Moreau, T., Baranger, K., Dade, S., Dallet-Choisy, S., Guyot, N., Zani, M.L., Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family (2008) Biochimie, 90, pp. 284-295
• Weldon, S., Taggart, C.C., Innate host defense functions of secretory leucoprotease inhibitor (2007) Exp Lung Res, 33, pp. 485-491
• Jin, F., Nathan, C.F., Radzioch, D., Ding, A., Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor (1998) Infect Immun, 66, pp. 2447-2452
• Henriksen, P.A., Hitt, M., Xing, Z., Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-κB-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli (2004) J Immunol, 172, pp. 4535-4544
• Taggart, C.C., Cryan, S.A., Weldon, S., Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding (2005) J Exp Med, 202, pp. 1659-1668
• Ashcroft, G.S., Lei, K., Jin, W., Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing (2000) Nat Med, 6, pp. 1147-1153
• Hiemstra, P.S., Maassen, R.J., Stolk, J., Heinzel-Wieland, R., Steffens, G.J., Dijkman, J.H., Antibacterial activity of antileukoprotease (1996) Infect Immun, 64, pp. 4520-4524
• Simpson, A.J., Maxwell, A.I., Govan, J.R., Haslett, C., Sallenave, J.M., Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens (1999) FEBS Lett, 452, pp. 309-313
• Nishimura, J., Saiga, H., Sato, S., Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor (2008) J Immunol, 180, pp. 4032-4039
• Tseng, C.C., Tseng, C.P., Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement (2000) FEBS Lett, 475, pp. 232-236
• Ma, G., Greenwell-Wild, T., Lei, K., Jin, W., Swisher, J., Hardegen, N., Wild, C.T., Wahl, S.M., Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection (2004) J Exp Med, 200, pp. 1337-1346
• Gomez, S.A., Arguelles, C.L., Guerrieri, D., Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria (2009) Am J Respir Crit Care Med, 179, pp. 247-253
• Samsom, J.N., van der Marel, A.P., van Berkel, L.A., Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance (2007) J Immunol, 179, pp. 6588-6595
• Xu, W., He, B., Chiu, A., Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI (2007) Nat Immunol, 8, pp. 294-303
• Nakamura, A., Mori, Y., Hagiwara, K., Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice (2003) J Exp Med, 197, pp. 669-674
• Vroling, A.B., Konijn, T., Samsom, J.N., Kraal, G., The production of secretory leukocyte protease inhibitor by dendritic cells (2011) Mol Immunol, 48, pp. 630-636
• Nukiwa, T., Suzuki, T., Fukuhara, T., Kikuchi, T., Secretory leukocyte peptidase inhibitor and lung cancer (2008) Cancer Sci, 99, pp. 849-855
• Maffia, P.C., Zittermann, S.E., Scimone, M.L., Neutrophil elastase converts human immature dendritic cells into transforming growth factor-β1-secreting cells and reduces allostimulatory ability (2007) Am J Pathol, 171, pp. 928-937
• Kanof, M., Smith, P., Zola, H., Isolation of whole mononuclear cells from peripheral blood and cord blood (1996) Current Protocols in Immunology, 7 (1 SUPPL. 19), pp. 1173-1179. , In: Interscience W, ed., New York: John Wiley & Sons, Inc.
• Burzyn, D., Jancic, C.C., Zittermann, S., Keller Sarmiento, M.I., Fainboim, L., Rosenstein, R.E., Chuluyan, H.E., Decrease in cAMP levels modulates adhesion to fibronectin and immunostimulatory ability of human dendritic cells (2002) J Leukoc Biol, 72, pp. 93-100
• Sallenave, J.M., Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity (2010) Am J Respir Cell Mol Biol, 42, pp. 635-643
• Murata, E., Sharmin, S., Shiota, H., Shiota, M., Yano, M., Kido, H., The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis (2003) Curr Eye Res, 26, pp. 271-276
• Gipson, T.S., Bless, N.M., Shanley, T.P., Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury (1999) J Immunol, 162, pp. 3653-3662
• Mulligan, M.S., Lentsch, A.B., Huber-Lang, M., Guo, R.F., Sarma, V., Wright, C.D., Ulich, T.R., Ward, P.A., Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor (2000) Am J Pathol, 156, pp. 1033-1039
• Lentsch, A.B., Yoshidome, H., Warner, R.L., Ward, P.A., Edwards, M.J., Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion (1999) Gastroenterology, 117, pp. 953-961
• Kubes, P., Ward, P.A., Leukocyte recruitment and the acute inflammatory response (2000) Brain Pathol, 10, pp. 127-135
• Song, X., Zeng, L., Jin, W., Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis (1999) J Exp Med, 190, pp. 535-542
• Mosser, D.M., The many faces of macrophage activation (2003) J Leukoc Biol, 73, pp. 209-212
• Biswas, S.K., Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm (2010) Nat Immunol, 11, pp. 889-896
• Stout, R.D., Jiang, C., Matta, B., Tietzel, I., Watkins, S.K., Suttles, J., Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences (2005) J Immunol, 175, pp. 342-349
• Zhang, Y., DeWitt, D.L., McNeely, T.B., Wahl, S.M., Wahl, L.M., Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases (1997) J Clin Invest, 99, pp. 894-900
• Sehnert, B., Cavcic, A., Bohm, B., Kalden, J.R., Nandakumar, K.S., Holmdahl, R., Burkhardt, H., Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis (2004) Arthritis Rheum, 50, pp. 2347-2359
• Sano, C., Shimizu, T., Sato, K., Kawauchi, H., Tomioka, H., Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-β (TGF-β), by lipopolysaccharide-stimulated macrophages (2000) Clin Exp Immunol, 121, pp. 77-85
• Lentsch, A.B., Jordan, J.A., Czermak, B.J., Diehl, K.M., Younkin, E.M., Sarma, V., Ward, P.A., Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation (1999) Am J Pathol, 154, pp. 239-247
• Varol, C., Yona, S., Jung, S., Origins and tissue-context-dependent fates of blood monocytes (2009) Immunol Cell Biol, 87, pp. 30-38
• Gordon, S., Taylor, P.R., Monocyte and macrophage heterogeneity (2005) Nat Rev Immunol, 5, pp. 953-964
• Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation (2008) Nat Rev Immunol, 8, pp. 958-969

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------